site stats

Cytek earnings

WebFeb 23, 2024 · Cytek Biosciences expects full year 2024 revenue to be in the range of $160 million to $168 million. Cytek will host a conference call to discuss the fourth quarter … WebApr 8, 2024 · Cytek Biosciences Inc.’s market cap currently stands at around $1.18 billion, with investors looking forward to this quarter’s earnings report slated for Feb 28, 2024. Analysts project the company’s earnings per share (EPS) to be $0.03, which has seen fiscal year 2024 EPS growth forecast to increase to $0.21 and about $0.33 for fiscal ...

Cytek Biosciences reports mixed Q3 earnings; reaffirms FY22 guidance

WebMay 11, 2024 · Other Ticker Details CTKB Company Name Cytek Biosciences Inc Earnings Call Date 11-05-2024 Time (ET) 17:00:00 Fiscal Quarter Q1 Fiscal Year WebApr 11, 2024 · Cytek Biosciences Inc’s price-earnings (P/E) ratio is currently at 568.0, which is high compared to the Advanced Medical Equipment & Technology industry … joshua moore rn facebook https://daisyscentscandles.com

Wenbin Jiang Sells 20,000 Shares of Cytek Biosciences, Inc.

WebFeb 24, 2024 · Cytek Biosciences has confirmed that its next quarterly earnings report will be published on Tuesday, February 28th, 2024. Cytek Biosciences will be holding an earnings conference call on Tuesday, February 28th at 4:30 PM Eastern. Interested parties can register for or listen to the call.. WebFeb 24, 2024 · Cytek Biosciences, Inc. (NASDAQ:NASDAQ:CTKB) Q4 2024 Earnings Conference Call February 23, 2024 5:00 PM ETCompany ParticipantsAlex Khan - Investor RelationsWenbin Jiang - Chief Executive... WebMar 1, 2024 · Cytek Biosciences, Inc. (CTKB) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to … joshua moore attorney jefferson city mo

Encompass Health (EHC) Up 32% in 6 Months: More Room to Run?

Category:Investor Events Cytek Biosciences

Tags:Cytek earnings

Cytek earnings

CTKB Stock Price Cytek Biosciences Inc. Stock Quote (U.S.: …

WebNov 9, 2024 · 2024 Outlook: Cytek Biosciences continues to expect full year 2024 revenue to be closer to the high end of the range of $160 million to $168 million vs. consensus of … WebFeb 23, 2024 · Total revenue was $38.9 million for the fourth quarter and $128.0 million for the full year of 2024, representing 27% and 38% increases over the …

Cytek earnings

Did you know?

WebApr 11, 2024 · The Zacks Consensus Estimate for Encompass Health’s 2024 earnings is pegged at $3.07 per share, indicating a 7.7% increase from the prior-year reported figure. The consensus mark for 2024... WebApr 13, 2024 · Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) CEO Wenbin Jiang sold 20,000 shares of Cytek Biosciences stock in a transaction that occurred on Monday, April 10th.The stock was sold at an average price of $8.88, for a total transaction of $177,600.00. Following the sale, the chief executive officer now owns 7,684,439 shares …

WebCytek Biosciences Reports Second Quarter 2024 Financial Results Earnings Per Share Estimated Reported Quarterly Earnings Surprise Amount Yearly Earnings Forecast Quarterly Earnings... WebMar 1, 2024 · Cytek Biosciences, Inc., which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $48.34 million for the quarter ended December 2024, missing the Zacks Consensus...

WebFeb 28, 2024 · Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results Full year 2024 revenue increased 28%, or 34% on constant currency basis, compared to prior year Provides full year 2024 revenue guidance of $225 million to $235 million, or growth of 37% to 43% over full year 2024 WebSep 30, 2024 · Cytek Biosciences continues to expect full year 2024 revenue to be closer to the high end of the range of $160 million to $168 million. Webcast Information. Cytek will host a conference call to discuss the third quarter 2024 financial results on Wednesday, November 9, 2024, at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

WebNov 9, 2024 · Cytek Biosciences, Inc. , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $40.48 million for the quarter ended September 2024, missing the Zacks...

WebFounded 1992 Status Public Employees 583 Stock Symbol CTKB Investments 4 Share Price $8.75 (As of Thursday Closing) General Information Description Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. how to listen to glenn beck radioWebApr 12, 2024 · On Tuesday, March 7th, Wenbin Jiang sold 20,000 shares of Cytek Biosciences stock. The shares were sold at an average price of $10.13, for a total value of $202,600.00. joshua moore twitterWebApr 11, 2024 · Cytek Biosciences (NASDAQ:CTKB) has a market capitalization of $1.22 billion and generates $164.04 million in revenue each year. The company earns $2.58 … joshua moehling author